{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T09:16:48Z","timestamp":1777627008773,"version":"3.51.4"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010882","name":"Tianjin Municipal Education Commission","doi-asserted-by":"publisher","award":["2024ZD044"],"award-info":[{"award-number":["2024ZD044"]}],"id":[{"id":"10.13039\/501100010882","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010882","name":"Tianjin Municipal Education Commission","doi-asserted-by":"publisher","award":["2023KJ057"],"award-info":[{"award-number":["2023KJ057"]}],"id":[{"id":"10.13039\/501100010882","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017964","name":"Tianjin Municipal Health Commission","doi-asserted-by":"publisher","award":["2023008"],"award-info":[{"award-number":["2023008"]}],"id":[{"id":"10.13039\/100017964","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010104","name":"Tianjin Medical University","doi-asserted-by":"publisher","award":["2024XKZXY21"],"award-info":[{"award-number":["2024XKZXY21"]}],"id":[{"id":"10.13039\/501100010104","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010104","name":"Tianjin Medical University","doi-asserted-by":"publisher","award":["2024XKZXY07"],"award-info":[{"award-number":["2024XKZXY07"]}],"id":[{"id":"10.13039\/501100010104","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006606","name":"Natural Science Foundation of Tianjin Municipality","doi-asserted-by":"publisher","award":["21JCZDJC00450"],"award-info":[{"award-number":["21JCZDJC00450"]}],"id":[{"id":"10.13039\/501100006606","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.lfs.2025.123713","type":"journal-article","created":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T02:10:07Z","timestamp":1747620607000},"page":"123713","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Tumor cell-derived microparticles containing MTX (MTX-TMPs) in the treatment of cholangiocarcinoma by modulating MDSCs"],"prefix":"10.1016","volume":"375","author":[{"given":"Qi","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saifei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaolin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaojun","family":"Sui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zehan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dihua","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangyang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ximo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Xun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dapeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.lfs.2025.123713_bb0005","doi-asserted-by":"crossref","first-page":"13","DOI":"10.5009\/gnl15568","article-title":"Cholangiocarcinoma: current knowledge and new developments","volume":"11","author":"Blechacz","year":"2017","journal-title":"Gut Liver"},{"issue":"9","key":"10.1016\/j.lfs.2025.123713_bb0010","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/nrgastro.2011.131","article-title":"Clinical diagnosis and staging of cholangiocarcinoma","volume":"8","author":"Blechacz","year":"2011","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"10","key":"10.1016\/j.lfs.2025.123713_bb0015","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.4251\/wjgo.v13.i10.1229","article-title":"Role of autophagy in cholangiocarcinoma: an autophagy-based treatment strategy","volume":"13","author":"Koustas","year":"2021","journal-title":"World J. Gastrointest. Oncol."},{"issue":"9","key":"10.1016\/j.lfs.2025.123713_bb0020","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/s41575-020-0310-z","article-title":"Cholangiocarcinoma 2020: the next horizon in mechanisms and management","volume":"17","author":"Banales","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"23","key":"10.1016\/j.lfs.2025.123713_bb0025","doi-asserted-by":"crossref","first-page":"744","DOI":"10.21037\/atm.2019.12.37","article-title":"Cholangiocarcinoma: anatomical location-dependent clinical, prognostic, and genetic disparities","volume":"7","author":"Hang","year":"2019","journal-title":"Ann. Transl. Med."},{"issue":"11","key":"10.1016\/j.lfs.2025.123713_bb0030","doi-asserted-by":"crossref","first-page":"4413","DOI":"10.3390\/molecules28114413","article-title":"Chronic inflammation\u2019s transformation to cancer: a nanotherapeutic paradigm","volume":"28","author":"Sohrab","year":"2023","journal-title":"Molecules"},{"issue":"17","key":"10.1016\/j.lfs.2025.123713_bb0035","doi-asserted-by":"crossref","first-page":"13503","DOI":"10.3390\/ijms241713503","article-title":"Inflammation and digestive cancer","volume":"24","author":"Waldum","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.lfs.2025.123713_bb0040","doi-asserted-by":"crossref","first-page":"101","DOI":"10.21037\/hbsn.2017.01.02","article-title":"Epidemiology and risk factors: intrahepatic cholangiocarcinoma","volume":"6","author":"Gupta","year":"2017","journal-title":"Hepatobiliary Surg. Nutr."},{"issue":"10","key":"10.1016\/j.lfs.2025.123713_bb0045","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1002\/jhbp.386","article-title":"Appraisal of inflammation-based prognostic scores in patients with unresectable perihilar cholangiocarcinoma","volume":"23","author":"Okuno","year":"2016","journal-title":"J. Hepatobiliary Pancreat. Sci."},{"issue":"6","key":"10.1016\/j.lfs.2025.123713_bb0050","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1007\/s00432-022-04399-y","article-title":"Cancer-associated inflammation: pathophysiology and clinical significance","volume":"149","author":"P\u0119czek","year":"2023","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.lfs.2025.123713_bb0055","article-title":"The recent progress of myeloid-derived suppressor cell and its targeted therapies in cancers","volume":"4","author":"Ren","year":"2023","journal-title":"Media Commun."},{"issue":"6","key":"10.1016\/j.lfs.2025.123713_bb0060","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-006166","article-title":"G-MDSC-derived exosomes mediate the differentiation of M-MDSC into M2 macrophages promoting colitis-to-cancer transition","volume":"11","author":"Wang","year":"2023","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.lfs.2025.123713_bb0065","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jaut.2017.07.010","article-title":"Myeloid suppressor cells in cancer and autoimmunity","volume":"85","author":"Sica","year":"2017","journal-title":"J. Autoimmun."},{"issue":"4","key":"10.1016\/j.lfs.2025.123713_bb0070","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s00262-018-2264-3","article-title":"Role of myeloid regulatory cells (MRCs) in maintaining tissue homeostasis and promoting tolerance in autoimmunity, inflammatory disease and transplantation","volume":"68","author":"Amodio","year":"2019","journal-title":"Cancer Immunol. Immunother."},{"issue":"8","key":"10.1016\/j.lfs.2025.123713_bb0075","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/s41577-020-00490-y","article-title":"Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity","volume":"21","author":"Veglia","year":"2021","journal-title":"Nat. Rev. Immunol."},{"issue":"8","key":"10.1016\/j.lfs.2025.123713_bb0080","doi-asserted-by":"crossref","first-page":"4499","DOI":"10.4049\/jimmunol.0802740","article-title":"Myeloid-derived suppressor cells: linking inflammation and cancer","volume":"182","author":"Ostrand-Rosenberg","year":"2009","journal-title":"J. Immunol."},{"issue":"11","key":"10.1016\/j.lfs.2025.123713_bb0085","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.imbio.2013.07.003","article-title":"Modulation of CD8(+) T-cell activation events by monocytic and granulocytic myeloid-derived suppressor cells","volume":"218","author":"Schouppe","year":"2013","journal-title":"Immunobiology"},{"issue":"2","key":"10.1016\/j.lfs.2025.123713_bb0090","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1158\/0008-5472.CAN-05-1299","article-title":"Gr-1+CD115+ immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host","volume":"66","author":"Huang","year":"2006","journal-title":"Cancer Res."},{"issue":"10","key":"10.1016\/j.lfs.2025.123713_bb0095","doi-asserted-by":"crossref","first-page":"4336","DOI":"10.1182\/blood-2006-09-046201","article-title":"Expansion of spleen myeloid suppressor cells represses NK cell cytotoxicity in tumor-bearing host","volume":"109","author":"Liu","year":"2007","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.lfs.2025.123713_bb0100","doi-asserted-by":"crossref","first-page":"977","DOI":"10.4049\/jimmunol.179.2.977","article-title":"Cross-talk between myeloid-derived suppressor cells and macrophages subverts tumor immunity toward a type 2 response","volume":"179","author":"Sinha","year":"2007","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.lfs.2025.123713_bb0105","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.imbio.2012.08.271","article-title":"Myeloid derived suppressor cells (MDSCs) can induce the generation of Th17 response from na\u00efve CD4+ T cells","volume":"218","author":"Chatterjee","year":"2013","journal-title":"Immunobiology"},{"issue":"11","key":"10.1016\/j.lfs.2025.123713_bb0110","doi-asserted-by":"crossref","first-page":"7424","DOI":"10.3390\/ijms12117424","article-title":"Distribution and clinical significance of Th17 cells in the tumor microenvironment and peripheral blood of pancreatic cancer patients","volume":"12","author":"He","year":"2011","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.lfs.2025.123713_bb0115","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1007\/s13277-015-4743-x","article-title":"Immunotherapy of biliary tract cancer","volume":"37","author":"Chai","year":"2016","journal-title":"Tumour Biol."},{"issue":"21","key":"10.1016\/j.lfs.2025.123713_bb0120","doi-asserted-by":"crossref","first-page":"15563","DOI":"10.3390\/ijms242115563","article-title":"The arising role of extracellular vesicles in cholangiocarcinoma: a rundown of the current knowledge regarding diagnostic and therapeutic approaches","volume":"24","author":"Trifylli","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2025.123713_bb0125","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/978-1-4939-7253-1_35","article-title":"Therapeutic use of tumor cell-derived extracellular vesicles","volume":"1660","author":"Liu","year":"2017","journal-title":"Methods Mol. Biol."},{"issue":"7","key":"10.1016\/j.lfs.2025.123713_bb0130","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/s41551-020-0583-0","article-title":"Methotrexate-loaded tumour-cell-derived microvesicles can relieve biliary obstruction in patients with extrahepatic cholangiocarcinoma","volume":"4","author":"Gao","year":"2020","journal-title":"Nat. Biomed. Eng."},{"issue":"2","key":"10.1016\/j.lfs.2025.123713_bb0135","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1158\/2326-6066.CIR-14-0177","article-title":"Cell-free tumor microparticle vaccines stimulate dendritic cells via cGAS\/STING signaling","volume":"3","author":"Zhang","year":"2015","journal-title":"Cancer Immunol. Res."},{"issue":"6","key":"10.1016\/j.lfs.2025.123713_bb0140","doi-asserted-by":"crossref","DOI":"10.1002\/cpz1.144","article-title":"Characterization and functional analysis of tumor-derived microparticles","volume":"1","author":"Ma","year":"2021","journal-title":"Curr. Protoc."},{"issue":"4","key":"10.1016\/j.lfs.2025.123713_bb0145","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1080\/13543784.2021.1865308","article-title":"Targeting the tumor microenvironment in cholangiocarcinoma: implications for therapy","volume":"30","author":"Wang","year":"2021","journal-title":"Expert Opin. Investig. Drugs"},{"issue":"Suppl. 1","key":"10.1016\/j.lfs.2025.123713_bb0150","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/liv.14098","article-title":"The tumour microenvironment and immune milieu of cholangiocarcinoma","volume":"39","author":"Fabris","year":"2019","journal-title":"Liver Int."},{"issue":"2","key":"10.1016\/j.lfs.2025.123713_bb0155","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/MOG.0000000000000613","article-title":"Immune contexture of cholangiocarcinoma","volume":"36","author":"Paillet","year":"2020","journal-title":"Curr. Opin. Gastroenterol."},{"issue":"2","key":"10.1016\/j.lfs.2025.123713_bb0160","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/MOG.0000000000000609","article-title":"Cancer-associated fibroblasts in cholangiocarcinoma","volume":"36","author":"Vaquero","year":"2020","journal-title":"Curr. Opin. Gastroenterol."},{"issue":"10","key":"10.1016\/j.lfs.2025.123713_bb0165","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1038\/s41423-022-00892-z","article-title":"Macrophages\u2019 M1 or M2 by tumor microparticles: lysosome makes decision","volume":"19","author":"Tang","year":"2022","journal-title":"Cell. Mol. Immunol."},{"issue":"1","key":"10.1016\/j.lfs.2025.123713_bb0170","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/s41467-020-20723-x","article-title":"Boosting anti-PD-1 therapy with metformin-loaded macrophage-derived microparticles","volume":"12","author":"Wei","year":"2021","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.lfs.2025.123713_bb0175","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1158\/2326-6066.CIR-16-0297","article-title":"Myeloid-derived suppressor cells","volume":"5","author":"Gabrilovich","year":"2017","journal-title":"Cancer Immunol. Res."},{"issue":"7647","key":"10.1016\/j.lfs.2025.123713_bb0180","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/nature21676","article-title":"Effective combinatorial immunotherapy for castration-resistant prostate cancer","volume":"543","author":"Lu","year":"2017","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.lfs.2025.123713_bb0185","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.ccr.2004.08.031","article-title":"Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis","volume":"6","author":"Yang","year":"2004","journal-title":"Cancer Cell"},{"issue":"10","key":"10.1016\/j.lfs.2025.123713_bb0190","doi-asserted-by":"crossref","first-page":"5380","DOI":"10.1172\/JCI137110","article-title":"Targeting tumor-associated macrophages and granulocytic myeloid-derived suppressor cells augments PD-1 blockade in cholangiocarcinoma","volume":"130","author":"Loeuillard","year":"2020","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.lfs.2025.123713_bb0195","doi-asserted-by":"crossref","DOI":"10.4161\/21624011.2014.954829","article-title":"Myeloid derived suppressor cells-an overview of combat strategies to increase immunotherapy efficacy","volume":"4","author":"Draghiciu","year":"2015","journal-title":"Oncoimmunology"},{"issue":"20","key":"10.1016\/j.lfs.2025.123713_bb0200","doi-asserted-by":"crossref","first-page":"3542","DOI":"10.3390\/cancers16203542","article-title":"Tumor immune microenvironment in intrahepatic cholangiocarcinoma: regulatory mechanisms, functions, and therapeutic implications","volume":"16","author":"Frega","year":"2024","journal-title":"Cancers"},{"issue":"8","key":"10.1016\/j.lfs.2025.123713_bb0205","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1007\/s11864-024-01243-y","article-title":"Recent advances in immunotherapy for advanced biliary tract cancer","volume":"25","author":"Yue","year":"2024","journal-title":"Curr. Treat. Options in Oncol."},{"key":"10.1016\/j.lfs.2025.123713_bb0210","doi-asserted-by":"crossref","first-page":"1037945","DOI":"10.3389\/fimmu.2023.1037945","article-title":"Immune microenvironment of cholangiocarcinoma: biological concepts and treatment strategies","volume":"14","author":"Yu","year":"2023","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.lfs.2025.123713_bb0215","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ccell.2021.12.006","article-title":"Proteogenomic characterization identifies clinically relevant subgroups of intrahepatic cholangiocarcinoma","volume":"40","author":"Dong","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.lfs.2025.123713_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmed.2025.01.008","article-title":"Molecular subtypes of intrahepatic cholangiocarcinoma","author":"De Santis","year":"2025","journal-title":"Trends Mol. Med."},{"issue":"4","key":"10.1016\/j.lfs.2025.123713_bb0225","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1158\/0008-5472.CAN-24-1173","article-title":"Mapping of the T-cell landscape of biliary tract cancer unravels anatomic subtype-specific heterogeneity","volume":"85","author":"Nie","year":"2025","journal-title":"Cancer Res."},{"key":"10.1016\/j.lfs.2025.123713_bb0230","doi-asserted-by":"crossref","first-page":"1517959","DOI":"10.3389\/fimmu.2025.1517959","article-title":"Immunocytes in the tumor microenvironment: recent updates and interconnections","volume":"16","author":"Yu","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lfs.2025.123713_bb0235","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.619253","article-title":"Myeloid-derived suppressor cell differentiation in cancer: transcriptional regulators and enhanceosome-mediated mechanisms","volume":"11","author":"Fultang","year":"2021","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.lfs.2025.123713_bb0240","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.3390\/ijms19061803","article-title":"STAT3 in tumor-associated myeloid cells: multitasking to disrupt immunity","volume":"19","author":"Su","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2025.123713_bb0245","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.3389\/fimmu.2019.01804","article-title":"The CCAAT\/enhancer-binding protein family: its roles in MDSC expansion and function","volume":"10","author":"Wang","year":"2019","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.lfs.2025.123713_bb0250","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.cmet.2018.04.022","article-title":"Aerobic glycolysis controls myeloid-derived suppressor cells and tumor immunity via a specific CEBPB isoform in triple-negative breast cancer","volume":"28","author":"Li","year":"2018","journal-title":"Cell Metab."},{"issue":"5","key":"10.1016\/j.lfs.2025.123713_bb0255","first-page":"507","article-title":"c-Rel is a myeloid checkpoint for cancer immunotherapy","volume":"1","author":"Li","year":"2020","journal-title":"Nat. Can."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320525003480?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320525003480?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:47:58Z","timestamp":1777423678000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320525003480"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":51,"alternative-id":["S0024320525003480"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2025.123713","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tumor cell-derived microparticles containing MTX (MTX-TMPs) in the treatment of cholangiocarcinoma by modulating MDSCs","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2025.123713","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"123713"}}